Efficacy and Safety of Abiraterone Acetate in an Elderly Patient Subgroup (Aged 75 and Older) with Metastatic Castration-resistant Prostate Cancer After Docetaxel-based Chemotherapy-Reference-Cited by-同舟云学术

Efficacy and Safety of Abiraterone Acetate in an Elderly Patient Subgroup (Aged 75 and Older) with Metastatic Castration-resistant Prostate Cancer After Docetaxel-based Chemotherapy

Published:2014-05 Issue:5 Volume:65 Page:875-883
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Mulders Peter F.A.,Molina Arturo,Marberger Michael,Saad Fred,Higano Celestia S.,Chi Kim N.,Li Jinhui,Kheoh Thian,Haqq Christopher M.,Fizazi Karim

Publisher

Elsevier BV

Subject

Urology

Reference34 articles.

1. World population prospects: the 2010 revision, highlights and advance tables,2010

2. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

3. Prostate cancer in the elderly: frequency of advanced disease at presentation and disease-specific mortality;Scosyrev;Cancer,2012

4. Individualized decision-making for older men with prostate cancer: balancing cancer control with treatment consequences across the clinical spectrum;Sajid;Semin Oncol,2011

5. Treating prostate cancer in elderly men: how does aging affect the outcome?;Shelke;Curr Treat Options Oncol,2011

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Pharmacokinetic Follow-Up of Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer;International Journal of Molecular Sciences;2024-05-31

2. Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non‐metastatic high‐risk prostate cancer (SPCG 19/GRand‐P);BJU International;2024-03-12

3. Adverse Events of Abiraterone Acetate vs Enzalutamide;Urology Practice;2023-07

4. A national questionnaire survey of Japanese urologists on treatment perspectives for elderly prostate cancer patients;International Journal of Urology;2023-06-23

5. Safety and Efficacy of [¹⁷⁷Lu]-PSMA-I&T Radioligand Therapy in Octogenarians with Metastatic Castration-Resistant Prostate Cancer: Report on 80 Patients over the Age of 80 Years;Journal of Nuclear Medicine;2023-06-15